Table 2 Clinical characteristics of HBV-infected mothers at delivery
|  | Intervention group (n = 34) | Non-intervention group (n = 15) | P value |
|---|---|---|---|
Age-yr | 27.50 (26.00,30.00) | 26.00 (24.00,32.00) | 0.535 |
Gravidity | 1.00 (1.00,2.00) | 1.00 (1.00,2.00) | 0.774 |
Delivery by means of cesarean section — no. (%) | 11 (32.35%) | 5(33.33%) |  > 0.999 |
Gestational age—wk | 39.50 (39.00,40.00) | 39.00 (38.00,39.00) | 0.080 |
Duration of antiviral intervention—dy | 89.50 (72.00, 100.0) | - |  |
LDT treatment-no.(%) | 24(70.59%) | - | Â |
TDF treatment-no.(%) | 10(29.41%) | - | Â |
ALT(U/L) | 16.00(12.50,20.00) | 20.00(15.00,35.00) | 0.113 |
AST(U/L) | 21.00(17.00,27.00) | 24.00(16.00,30.00) | 0.624 |
HBsAg(IU/ml) | 15,549(3644,32,316) | 8456(2229,52,000) | 0.862 |
HBeAg(COI) | 1320(809.6,1548) | 1448(1174,1767) | 0.219 |
HBV DNA(log10 IU/ml) | 3.38 (2.38,4.37) | 7.70 (6.58,8.57) |  < 0.001 |